BERWYN, PA — AscellaHealth has announced its role as a Silver Sponsor of the World Orphan Drug Congress USA (WODC), which will convene from April 22-24, 2025, at the Boston Convention Center. A provider of innovative specialty pharmaceutical solutions, AscellaHealth aims to spotlight its commitment to improving patient access to therapies for complex, chronic, and rare conditions.
A highlight of the event will be a roundtable discussion on April 23 at 2 p.m., led by Donovan Quill, Executive Vice President of Life Science Strategies at AscellaHealth. The discussion, titled “The Truths and Myths of Building a Patient-First Exclusive Distribution Program,” will address key elements of the exclusive distribution model for specialty pharmaceuticals, emphasizing its potential to improve oversight, streamline supply chain processes, and enhance the delivery of life-changing medications. Quill noted, “My hope is that our roundtable will spark meaningful discussion and clear up the many myths around exclusive distribution as well as provide actionable strategies that truly put patients first while optimizing supply chain performance.”
Conference attendees will also have the chance to interact with AscellaHealth experts at booth #527, where the company will showcase its tailored, end-to-end solutions designed to help life sciences organizations optimize commercialization, distribution, and patient access strategies.
The World Orphan Drug Congress USA brings together professionals from across the pharmaceutical sector to exchange ideas and strategies for advancing treatments for rare diseases. AscellaHealth’s active participation underscores its dedication to creating innovative approaches that benefit patients and drive industry progress.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.